Article
Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice
1 May 2021
Abstract excerpt
Targeting the signaling pathway of growth differentiation factor 8 (GDF8), also known as myostatin, has been regarded as a promising strategy to increase muscle mass in the elderly and in patients. Accumulating evidence in animal models and clinical trials has indicated that a rational approach is to inhibit a limited number of transforming growth factor β (TGF-β) family ligands, including GDF8 and activin A,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
